New drug donanemab seen as turning point in fight against Alzheimer’s
As reported by The Times, more than 720,000 people in Britain could benefit from groundbreaking new drugs that slow the progression of Alzheimer’s disease, experts keep reading
As reported by The Times, more than 720,000 people in Britain could benefit from groundbreaking new drugs that slow the progression of Alzheimer’s disease, experts keep reading
As reported by The Times, a drug to boost brain function in old age has moved a step closer after scientists found that a single keep reading
As reported by The Times, a blood test that can detect people at early risk of Alzheimer’s is a step closer after scientists implicated a keep reading
As reported by the BBC, we could be entering the era of Alzheimer’s treatments, after the second drug in under a year has been shown keep reading
As reported by the BBC, Lecanemab is the first drug to slow the destruction of the brain in Alzheimer’s has been heralded as momentous The keep reading
As reported by the BBC, experts say trial results of a drug appearing to slow Alzheimer’s disease represent a ‘historic moment’ Pharmaceutical companies Eisai and keep reading
Copyright © 2024 | Practice Business | Intelligent Media Solutions | This site is intended for healthcare professionals only.